Let’s turn ideas into solutions.

Your ideas. Our solutions.

Abzena are committed to providing you with innovative solutions that streamline, and move your new medicines forward to patients in need.

Meeting your challenges

Our innovative solutions accelerate your drug program from discovery and development, through to commercialization and launch. No matter the challenge, at all stages, we are always focused on understanding and meeting your program’s goals.

Abzena are uniquely positioned, and ready to partner with you, to move your complex biologic or bioconjugate and ADC program’s forwards. Explore our solutions below and see how we can help you accelerate your drug development program.

Explore our innovative solutions

AbZelect™ & AbZelectPRO™

High-yielding platforms that accelerates cell line development.

Explore AbZelect™

ThioBridge™

Next-generation site-specific conjugation linker technology.

Explore ThioBridge™

EpiScreen® 2.0

Next-generation in-silico, MAPPS, and immunogenicity assays.

Explore EpiScreen® 2.0

LabZient™

Advanced analytical platform to expedite IND submission.

Explore LabZient™

Composite Human Antibody™

Design safer, more effective, humanized antibodies.

Explore Composite Human Antibody™

Composite Proteins™

Design safer, more effective, deimmunized therapeutic proteins.

Explore Composite Proteins™

We are ready to accelerate your drug development program

Solutions that meet your goals, development phase challenges and minimize risk.

No matter the challenge, our solutions can help accelerate your drug program from early discovery and development, through to commercialization. Discover how we can help your success.

What is your goal?

Whether you’re looking to progress through preclinical to IND/CTA, searching for a commercial partner, or have a question about the best strategy for your molecule type, our experts can help you meet your drug development goals.

By development stage

The global integration of scientific capabilities across our facilities in the US and the UK enable us to provide a complete assessment of the developability of your candidate. Our experience and processes across all stages of biologics and bioconjugate drug development allow us to quickly identify the best drug candidates for your program, faster. Our agile approach to project management ensures that your drug development programs are delivered on-time and on-budget, mitigating risks, and shortening timescales to IND. Take a glimpse at our early development capabilities and get in touch today.

Drug Developability: the Derisker

Starting smart, finishing fast, with Abzena.

Why Abzena?

We are the leading biologic, bioconjugate and ADC CDMO + CRO who anticipates and meets your drug development challenges. Find out more about who Abzena are and why, together, we can make a difference to patients lives and move medicine forwards.

Moving medicine forwards.

It’s what we do. At Abzena, we know how to take your ideas forward and develop a successful medicine of the future.